Lilly files more lawsuits over sales of copycat Zepbound
Eli Lilly has sued three more companies that claim to be selling versions of tirzepatide, the main ingredient in the drugmaker’s weight loss treatment Zepbound …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
